
Publications
Research papers, anchored to PubMed (PMID) or DOI.
154 cards, each checked against its primary source
Search the catalog
Filters
Closeness to humans
Closeness to humans:Any
Order:Newest
Card descriptions are written in Russian for now; English text is coming.
VOYAGER individual-patient meta-analysis (Karlson et al.)
PMID 26246463
38 052 exposures.
No news yet
SOUL: McGuire DK et al., N Engl J Med 2025
DOI 10.1056/NEJMoa2501006
No news yet
SELECT: Lincoff AM et al., N Engl J Med 2023
DOI 10.1056/NEJMoa2307563
No news yet
MacIntyre et al., Circulation 2022
DOI 10.1161/CIRCULATIONAHA.121.056015
No news yet
FIDELIO-DKD: Bakris et al., N Engl J Med 2020
DOI 10.1056/NEJMoa2025845
No news yet
FINEARTS-HF: Solomon et al., N Engl J Med 2024
DOI 10.1056/NEJMoa2407107
No news yet
J Clin Hypertens 2023 meta-analysis: weight loss and BP
PMID 37141231
35 studies / 3219 people.
No news yet
Luo S et al., Front Pharmacol 2026 (randomized open-label carotid plaque trial)
PMID 42723921
ChiCTR2200058389.
No news yet
IMPROVE-IT: Cannon CP et al., N Engl J Med 2015
DOI 10.1056/NEJMoa1410489
No news yet
PRECISE-IVUS: Tsujita K et al., JACC 2015
PMID 26227186
No news yet
Sun J et al., Int J Cardiovasc Imaging 2015 (LRNC reproducibility)
PMID 25216871
Multicenter same-magnet scan–rescan reproducibility, 68 subjects.
No news yet
CLEAR Outcomes (bempedoic acid)
PMID 36876740
13,970 statin-intolerant patients; primary MACE-4 11.7% vs 13.3%, HR 0.87 (95% CI 0.79–0.96).
No news yet
CLEAR Harmony (bempedoic acid)
PMID 30865796
Bempedoic acid added to maximally tolerated statin reduced LDL-C by 18.1 percentage points vs placebo at Week 12.
No news yet
ODYSSEY OUTCOMES (alirocumab)
PMID 30403574
No news yet
PACMAN-AMI: Räber L et al., JAMA 2022
PMID 35368058
Alirocumab + high-intensity statin after acute MI, serial IVUS/NIRS/OCT at 52 weeks.
No news yet
Cholesterol Treatment Trialists’ Collaboration, Lancet 2010
PMID 21067804
Individual-participant meta-analysis of 26 randomized statin trials (~170,000 participants).
No news yet
Brinjikji W et al., meta-analysis of serial high-resolution carotid MRI
PMID 28187866
7 studies, 361 patients.
No news yet
Du R et al., BMC Cardiovasc Disord 2014 (serial carotid MRI, rosuvastatin)
PMID 25022285
Serial carotid MRI, rosuvastatin 5–20 mg/day.
No news yet
SATURN: Nicholls SJ et al., N Engl J Med 2011
PMID 22085316
Rosuvastatin 40 mg vs atorvastatin 80 mg, serial IVUS, 104 weeks, n=1,039.
No news yet
ASTEROID: Nissen SE et al., JAMA 2006
PMID 16533939
Rosuvastatin 40 mg/day, serial coronary IVUS, 24 months, 349 evaluable patients.
No news yet
VICTORION-PLAQUE peer-reviewed design
PMID 40769373
No news yet
REMBRANDT design protocol, American Heart Journal 2025
PMID 40683616
No news yet
Charles et al., ELXR engineering (bioRxiv)
DOI 10.64898/2026.01.13.698514v1
Allosteric control improved potency/specificity; in-vivo PCSK9 silencing remains preclinical.
No news yet
Snip et al., Biomolecules 2022 (2HPβCD in ApoE-KO)
PMID 36139044
Free 2HPβCD stimulated macrophage cholesterol efflux but did not induce regression of established lesions in the tested ApoE-KO model.
No news yet